Interestingly, modified citrus pectin (a dietary supplement) has been used as an inhibiter of galectin-3 to block cardiac injury that is induced by acute kidney injury via the galectin-3 pathway [64] and may provide an easy initial molecule for clinical trials. The gene discussed is LGALS3; the disease is acute kidney injury.